Galapagos NV (GLPG), a biotechnology company, said on Monday that it has appointed Aaron Cox as Chief Financial Officer with effect from July 7 to succeed Thad Huston.
Earlier, Cox had served as CFO of Horizon Therapeutics Plc, which was acquired by Amgen.
Huston will remain with the company through July 31 to ensure a smooth transition of the responsibilities.
In connection with this appointment, Galapagos noted that it will issue new restricted stock units and subscription rights.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.